- Free from Publisher K Sivenius, J Pihlajamäki, J Partanen, L … - Diabetes care, 2004 - Am Diabetes Assoc RESULTS—The genetic screening identified four polymorphisms: C-106T, C-11G,
A11370G, and C19739A. The C and Z-2 alleles of the C-106T polymorphism and the
previously reported (CA) n repeat marker were more frequent in type 2 ... Cited by 10 - Related articles - BL Direct - All 5 versions
A Watarai, E Nakashima, Y Hamada, G … - Diabetic Medicine, 2006 - pubmedcentral.nih.gov There were no significant differences in genotypic or allelic distribution in
patients with or without ischaemic heart diseases, but there was a significant
increase in the frequency of the CT + TT genotype and T allele in patients ... Cited by 2 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org K Thamotharampillai, AKF Chan, B Bennetts, … - Diabetes care, 2006 - Am Diabetes Assoc RESULTS—Median time between first and last assessment was 7.0 years
(interquartile range 5.1–11.1), with a median of five assessments (four to
seven) per individual. At first assessment, median age was 12.7 years ... Cited by 9 - Related articles - BL Direct - All 5 versions
B Yang, A Millward, A Demaine - BBA-Molecular Basis of Disease, 2003 - Elsevier Studies have shown that polymorphisms located at positions −106 and
approximately −2100 base pairs (5′ALR2) in the regulatory region of the
aldose reductase gene are associated with susceptibility to microvascular ... Cited by 16 - Related articles - All 4 versions
KC Donaghue, SH Margan, AK Chan, B … - Diabetic Medicine, 2005 - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 12 - Related articles - BL Direct - All 4 versions
Y Harati - Neurologic clinics, 2007 - Elsevier Diabetic neuropathies are the most common types of neuropathies worldwide.
Although there has been significant progress in the understanding of the
clinical aspects of these conditions, many questions remain unanswered or ... Cited by 5 - Related articles - All 4 versions
K Sivenius, L Niskanen, R Voutilainen- … - Diabetic Medicine, 2004 - pt.wkhealth.com Results: The C and Z-2 alleles of the C-106T polymorphism and the (CA) n repeat
marker, respectively, were found to be more frequent in Type 2 diabetic subjects
than in non-diabetic subjects. The C and Z-2 alleles were in 60% linkage ... Cited by 14 - Related articles - BL Direct - All 5 versions
[CITATION] Effect of polymorphism of (AC) n in the 5′ end of aldose reductase gene on erythrocyte …
K Gosek, D Moczulski, E Zukowska- … - Nephron Exp Nephrol, 2005 - content.karger.com Background: Excessive flux through the polyol pathway has long been thought to
be involved in the pathogenesis of diabetic microvascular complications. Aldose
reductase (AR) is the first and rate-limiting enzyme in the pathway that ... Cited by 7 - Related articles - All 4 versions
I Mišur, K Žarković, A Barada, L Batelja, Z … - Acta Diabetologica, 2004 - Springer Abstract Advanced glycation endproducts (AGE) accumu- late over proteins as a
consequence of diabetic hyper- glycemia, and thus contribute to the pathogenesis
of diabet- ic complications. To improve the understanding of the pathology ... Cited by 17 - Related articles - All 4 versions
